“Computational Analysis of FDA-Approved Drugs for Potential Repurposing in Alzheimer’s Disease: Targeting MTOR and NGFR Pathways”. Science Essence Journal, vol. 42, no. 1, Jan. 2026, pp. 50-70, https://doi.org/10.69523/sej.2026.42.17130.